肾功能不全在统计学和临床上对抗癌药物安全性具有显著的有害影响。 - Suppr

Renal Dysfunction Has Statistically and Clinically Significant Deleterious Effects on Anticancer Drug Safety.

作者信息

Launay-Vacher Vincent

机构信息

Pitié-Salpêtrière University Hospital, Paris, France; and Cancer and the Kidney International Network, Brussels, Belgium

出版信息

J Clin Oncol. 2016 Jul 10;34(20):2428. doi: 10.1200/JCO.2015.65.1554. Epub 2016 May 16.

DOI:10.1200/JCO.2015.65.1554

PMID:27185847

Abstract

摘要

相似文献

Renal Dysfunction Has Statistically and Clinically Significant Deleterious Effects on Anticancer Drug Safety.

J Clin Oncol. 2016 Jul 10;34(20):2428. doi: 10.1200/JCO.2015.65.1554. Epub 2016 May 16.

[Anticancer drugs management in renal insufficiency patients].

Bull Cancer. 2012 Mar 1;99(3):323-31. doi: 10.1684/bdc.2011.1489.

Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study.

Cancer. 2007 Sep 15;110(6):1376-84. doi: 10.1002/cncr.22904.

Pharmacokinetics and safety of cetuximab in a patient with renal dysfunction.

Cancer Chemother Pharmacol. 2014 Jun;73(6):1303-6. doi: 10.1007/s00280-014-2462-4. Epub 2014 Apr 6.

International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency.

Eur J Cancer. 2007 Jan;43(1):14-34. doi: 10.1016/j.ejca.2006.11.004.

Drug management of prostate cancer: prevalence and consequences of renal insufficiency.

Clin Genitourin Cancer. 2009 Oct;7(3):E83-9. doi: 10.3816/CGC.2009.n.029.

Eligibility of patients with renal impairment for Phase I trials: Time for a rethink?

Eur J Cancer. 2014 Nov;50(17):2893-6. doi: 10.1016/j.ejca.2014.09.001. Epub 2014 Sep 17.

[Renal insufficiency and breast cancer].

Bull Cancer. 2012 Mar 1;99(3):309-15. doi: 10.1684/bdc.2011.1478.

[Pharmacokinetics and impaired organic functions].

Bull Cancer. 2011 Nov;98(11):1347-54. doi: 10.1684/bdc.2011.1465.

[Nephrotoxicity induced by chemotherapy].

G Ital Nefrol. 2011 May-Jun;28(3):296-304.

引用本文的文献

Systemic therapy strategies for elderly patients with gastric cancer.

Ther Adv Med Oncol. 2025 Aug 16;17:17588359251363057. doi: 10.1177/17588359251363057. eCollection 2025.

Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancer.

ESMO Open. 2022 Dec;7(6):100633. doi: 10.1016/j.esmoop.2022.100633. Epub 2022 Nov 28.

Kidney transplantation in patients with previous renal cancer: a critical appraisal of current evidence and guidelines.

J Nephrol. 2019 Feb;32(1):57-64. doi: 10.1007/s40620-018-0542-y. Epub 2018 Oct 16.

Dose adjustment of cisplatin, etoposide, and ifosfamide according to kidney function: a retrospective analysis and implications for medication safety.

Naunyn Schmiedebergs Arch Pharmacol. 2018 Feb;391(2):219-229. doi: 10.1007/s00210-017-1456-2. Epub 2018 Jan 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Renal Dysfunction Has Statistically and Clinically Significant Deleterious Effects on Anticancer Drug Safety.

作者信息

Launay-Vacher Vincent

机构信息

Pitié-Salpêtrière University Hospital, Paris, France; and Cancer and the Kidney International Network, Brussels, Belgium

出版信息

J Clin Oncol. 2016 Jul 10;34(20):2428. doi: 10.1200/JCO.2015.65.1554. Epub 2016 May 16.

DOI:10.1200/JCO.2015.65.1554

PMID:27185847

Abstract

摘要

相似文献

Renal Dysfunction Has Statistically and Clinically Significant Deleterious Effects on Anticancer Drug Safety.

J Clin Oncol. 2016 Jul 10;34(20):2428. doi: 10.1200/JCO.2015.65.1554. Epub 2016 May 16.

[Anticancer drugs management in renal insufficiency patients].

Bull Cancer. 2012 Mar 1;99(3):323-31. doi: 10.1684/bdc.2011.1489.

Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study.

Cancer. 2007 Sep 15;110(6):1376-84. doi: 10.1002/cncr.22904.

Pharmacokinetics and safety of cetuximab in a patient with renal dysfunction.

Cancer Chemother Pharmacol. 2014 Jun;73(6):1303-6. doi: 10.1007/s00280-014-2462-4. Epub 2014 Apr 6.

International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency.

Eur J Cancer. 2007 Jan;43(1):14-34. doi: 10.1016/j.ejca.2006.11.004.

Drug management of prostate cancer: prevalence and consequences of renal insufficiency.

Clin Genitourin Cancer. 2009 Oct;7(3):E83-9. doi: 10.3816/CGC.2009.n.029.

Eligibility of patients with renal impairment for Phase I trials: Time for a rethink?

Eur J Cancer. 2014 Nov;50(17):2893-6. doi: 10.1016/j.ejca.2014.09.001. Epub 2014 Sep 17.

[Renal insufficiency and breast cancer].

Bull Cancer. 2012 Mar 1;99(3):309-15. doi: 10.1684/bdc.2011.1478.

[Pharmacokinetics and impaired organic functions].

Bull Cancer. 2011 Nov;98(11):1347-54. doi: 10.1684/bdc.2011.1465.

[Nephrotoxicity induced by chemotherapy].

G Ital Nefrol. 2011 May-Jun;28(3):296-304.

引用本文的文献

Systemic therapy strategies for elderly patients with gastric cancer.

Ther Adv Med Oncol. 2025 Aug 16;17:17588359251363057. doi: 10.1177/17588359251363057. eCollection 2025.

Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancer.

ESMO Open. 2022 Dec;7(6):100633. doi: 10.1016/j.esmoop.2022.100633. Epub 2022 Nov 28.

Kidney transplantation in patients with previous renal cancer: a critical appraisal of current evidence and guidelines.

J Nephrol. 2019 Feb;32(1):57-64. doi: 10.1007/s40620-018-0542-y. Epub 2018 Oct 16.

Dose adjustment of cisplatin, etoposide, and ifosfamide according to kidney function: a retrospective analysis and implications for medication safety.

Naunyn Schmiedebergs Arch Pharmacol. 2018 Feb;391(2):219-229. doi: 10.1007/s00210-017-1456-2. Epub 2018 Jan 2.

Renal Dysfunction Has Statistically and Clinically Significant Deleterious Effects on Anticancer Drug Safety.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Renal Dysfunction Has Statistically and Clinically Significant Deleterious Effects on Anticancer Drug Safety.

作者信息

机构信息

出版信息

相似文献

引用本文的文献